Use of polymeric materials in orally inhaled and nasal drug products.
To maintain a high standard of quality in the materials and components used in the container systems of orally inhaled and nasal drug products, manufacturers need to collaborate closely with all those in the supply chain. Best practices in information sharing, particularly in relation to change control, are outlined here.
Dohmeier
D M
DM
International Pharmaceutical Aerosol Consortium on Regulation and Science, Washington, District of Columbia, USA.
Norwood
D L
DL
Reckzuegel
G
G
Stults
C L M
CL
Nagao
L M
LM
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000284:Administration, Oral; D001672:Biocompatible Materials / Q000737:chemistry*; D064420:Drug-Related Side Effects and Adverse Reactions; D017408:Guidelines as Topic; D006801:Humans; D008420:Manufactured Materials / Q000592:standards*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D011786:Quality Control
D001672:Biocompatible Materials; D004364:Pharmaceutical Preparations; D011108:Polymers